AMA Accepting Applications for 2022 Joy in Medicine Health System Recognition Program

Translate to Spanish or other 102 languages!

The American Medical Association (AMA) is currently accepting applications from health care organizations for the 2022 Joy in Medicine™ Health System Recognition Program. Image for illustration purposes.
The American Medical Association (AMA) is currently accepting applications from health care organizations for the 2022 Joy in Medicine™ Health System Recognition Program. Image for illustration purposes.

Mega Doctor News

- Advertisement -

CHICAGO – The American Medical Association (AMA) is currently accepting applications from health care organizations for the 2022 Joy in Medicine™ Health System Recognition Program. The AMA distinction, now in its third year, recognizes health systems with a demonstrated commitment to reducing work-related burnout among care teams. The application process will close on March 31, 2022.


“While it is always important for health systems to focus on the well-being of care teams, the imperative is greater than ever as acute stress from combatting the COVID-19 pandemic has contributed to higher rates of work overload, anxiety, and depression,” said AMA President Gerald E. Harmon, M.D.

A recent AMA-led study found that 1 in 5 physicians and 2 in 5 nurses intend to leave their current practice within 2 years mainly due to higher levels of burnout, stress, workload, fear of infection, anxiety or depression due to COVID-19, and the number of years in practice.

Safeguarding and retaining the health care workforce is essential to achieving national health goals and the AMA recognition program offers a roadmap to guide health system leaders who are interested, engaged, and committed in efforts to fight the root causes of burnout in the health care workforce.

- Advertisement -

Candidates are evaluated according to their documented efforts to reduce system-level drivers of work-related burnout. Scoring criteria is based on demonstrated competencies in commitment, assessment, leadership, efficiency of practice environment, teamwork, and support. Interested health care organizations can visit the program application portal for more details.

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

No More Needles: FDA Approves First Daily Pill to Replace Injectable Cholesterol Drugs

The U.S. Food and Drug Administration approved Lipfendra (enlicitide), the first oral inhibitor of proprotein convertase subtilisin/kexin type 9 (PCSK9), as an adjunct to diet and exercise to reduce low-density lipoprotein cholesterol (LDL-C), or “bad” cholesterol, in adults with hypercholesterolemia, including those with heterozygous familial hypercholesterolemia (HeFH). Image source: Merck.com.

STHS Heart Ranks Among Nation’s Top Hospitals for Heart Attack Care

Every year, more than 800,000 people in the United States suffer a heart attack, according to the Centers for Disease Control and Prevention, an event that occurs approximately every 40 seconds.

DHR Health Burn Surgeon Urges Public to Avoid Preventable Risks

Many of the most serious burn and trauma injuries can be prevented by avoiding unnecessary risks, according to Dr. R. Dewayne Edwards, chief burn surgeon, surgical critical care and trauma surgeon at DHR Health, who said public awareness and timely medical care remain essential to improving patient outcomes.

Endocrine Society Outlines Strict Rules for Safe Testosterone Therapy

The Society’s Clinical Practice Guideline on testosterone replacement therapy in men with hypogonadism offers recommendations on appropriate testing and prescribing practices. 
- Advertisement -